Jacinto Fernández Sanromán

Jacinto Fernández Sanromán

Auto-generated profile, based on publicly available information

Jacinto Fernández Sanromán

Department of Oral and Maxillofacial Surgery, Povisa Medical Centre, Vigo, Spain

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 1998 in Journal of Cranio-Maxillofacial Surgery
Verified
Journal Article
Closed access
JSJ. Fernández Sanromán
J. Fernández Sanromán
JGJ.M. Gómez González
J.M. Gómez González
JHJ. Alonso del Hoyo
J. Alonso del Hoyo

1 June 2004 in International Journal of Oral and Maxillofacial Surgery
Verified
Journal Article
Closed access
JSJ.F Sanromán
J.F Sanromán

1 December 2013 in British Journal of Oral and Maxillofacial Surgery
Verified
Journal Article
Closed access
JLJOSÉ LÓPEZ-CEDRÚN
JOSÉ LÓPEZ-CEDRÚN
JSJ.F. Sanromán
J.F. Sanromán
AGAbel Garcia-Garcia
Abel Garcia-Garcia
MPM. Peñarrocha
M. Peñarrocha
JFJ.F. Feijoo
J.F. Feijoo
PDP. Diz
P. Diz

1 July 2016 in International Journal of Oral and Maxillofacial Surgery
Verified
Journal Article
Closed access
JSJ. Fernández Sanromán
J. Fernández Sanromán
MFM. Fernández Ferro
M. Fernández Ferro
ALA. Costas López
A. Costas López
JBJ. Arenaz Bua
J. Arenaz Bua
ALA. López
A. López

1 February 1994 in Journal of Oral and Maxillofacial Surgery
Verified
Journal Article
Closed access
JHJ. Alonso Del Hoyo
J. Alonso Del Hoyo
JSJ. Fernandez Sanroman
J. Fernandez Sanroman
JGJ.L. Gil-Diez
J.L. Gil-Diez
FGF.J. Diaz Gonzalez
F.J. Diaz Gonzalez

1 January 2012 in Medicina Oral Patología Oral y Cirugia Bucal
Verified
Journal Article
Open access
Marcio Diniz-FreitasMarcio Diniz-Freitas
Marcio Diniz-Freitas
JLJl. Lopez-Cedrun
Jl. Lopez-Cedrun
JFJ. Fernandez-Sanroman
J. Fernandez-Sanroman
AGAbel Garcia-Garcia
Abel Garcia-Garcia
JFJ. Fernandez-Feijoo
J. Fernandez-Feijoo
PDP. Diz-Dios
P. Diz-Dios
Objective: The objective of this study was to define the clinical characteristics of osteonecrosis of the jaws (ONJ) induced by oral bisphosphonates in a series of patients from a circumscribed area in northwest Spain. Study Design:A retrospective multicentre study was undertaken in 3 hospitals in an area with a radius less than 100 km in the Autonomous Community of Galicia (Spain). The medical records were reviewed and an oral examination was performed of patients diagnosed with oral bisphosphonate-related ONJ in the previous 3 years. Results: We detected 20 cases of ONJ (24 lesions) related to oral bisphosphonates (alendronate [16 patients] and ibandronate [4 patients]), which were mainly administered as treatment for osteoporosis (17 patients). The mean interval between initiation of treatment and confirmation of a diagnosis of ONJ was 66±43 months (range, 6-132 months); in 7 patients (35%) the interval was less than 36 months. The past history revealed hypertension in 13 cases (65%) and diabetes in 4 (20%); 7 patients (35%) were on corticosteroid treatment. Oral surgery had been previously performed in 13 patients (65%) and the remaining 7 patients (35%) had removable dental prostheses. The lesions most frequently affected the posterior mandible (62.5%). The majority of the lesions (75%) were classified as stage 2, although lesions were identified in all established clinical stages (including 2 stage 0 lesions). Conclusion: In conclusion, in the present series, ONJ induced by oral bisphosphonates typically develops in women around 70 years of age, taking alendronate, that underwent oral surgery. Most lesions are located in the posterior mandible and are classified as stage 2 at diagnosis. Some patients presented no known risk factors, suggesting that there may be risk factors still to be identified. There are well-defined patterns of clinical presentation that can facilitate early diagnosis of ONJ.